03 Sep Novo Nordisk Europe’s most valuable company based on closing price Posted at 17:34h in News by KMFSLLP 0 Comments 0 Likes Shares rose after the Danish pharmaceutical group launched its anti-obesity drug Wegovy in the UK
Sorry, the comment form is closed at this time.